Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 07 04:00PM ET
Dollar change
Percentage change
Index- P/E79.37 EPS (ttm)0.91 Insider Own1.62% Shs Outstand491.80M Perf Week-4.93%
Market Cap35.36B Forward P/E23.60 EPS next Y3.05 Insider Trans0.00% Shs Float483.83M Perf Month-2.40%
Income450.00M PEG4.96 EPS next Q0.68 Inst Own51.69% Short Float / Ratio0.49% / 2.81 Perf Quarter-12.60%
Sales9.27B P/S3.81 EPS this Y21.37% Inst Trans- Short Interest2.36M Perf Half Y-8.90%
Book/sh40.86 P/B1.76 EPS next Y12.04% ROA1.57% Target Price87.77 Perf Year7.12%
Cash/sh2.14 P/C33.61 EPS next 5Y16.01% ROE2.26% 52W Range63.78 - 86.20 Perf YTD4.89%
Dividend0.26 P/FCF50.66 EPS past 5Y5.41% ROI1.80% 52W High-16.59% Beta0.90
Dividend %0.36% Quick Ratio1.29 Sales past 5Y5.55% Gross Margin55.42% 52W Low12.73% ATR1.39
Employees25178 Current Ratio2.21 Sales Q/Q8.83% Oper. Margin11.94% RSI (14)44.49 Volatility1.28% 1.51%
OptionableYes Debt/Eq0.25 EPS Q/Q75.27% Profit Margin4.85% Rel Volume0.67 Prev Close71.93
ShortableYes LT Debt/Eq0.24 EarningsNov 14 AMC Payout32.25% Avg Volume839.54K Price71.90
Recom1.69 SMA20-1.30% SMA50-2.22% SMA200-5.74% Volume565,862 Change-0.04%
Date Action Analyst Rating Change Price Target Change
Dec-04-23Downgrade Morgan Stanley Equal-Weight → Underweight $85 → $65
Aug-17-23Upgrade JP Morgan Neutral → Overweight $79.80 → $89.30
May-30-23Resumed Morgan Stanley Equal-Weight $85
May-10-23Upgrade Robert W. Baird Neutral → Outperform $75 → $90
Mar-01-23Upgrade Societe Generale Sell → Hold
Dec-22-22Initiated Mizuho Buy $85
Nov-17-22Downgrade Societe Generale Hold → Sell
Aug-11-22Downgrade Societe Generale Buy → Hold
May-13-22Resumed Credit Suisse Outperform $96
May-12-22Upgrade Stephens Equal-Weight → Overweight $86 → $92
Nov-15-23 12:31PM
Nov-14-23 04:30PM
Nov-08-23 09:03AM
Oct-30-23 09:41AM
10:04AM Loading…
Oct-11-23 10:04AM
Oct-10-23 08:01AM
Oct-02-23 09:35AM
Sep-09-23 01:01AM
Sep-06-23 04:30PM
Aug-17-23 09:39AM
Aug-16-23 02:08PM
Aug-15-23 04:30PM
Jul-17-23 07:43AM
06:42PM Loading…
Jul-11-23 06:42PM
May-22-23 04:51PM
May-19-23 11:16AM
May-16-23 06:40AM
May-15-23 08:08AM
May-10-23 12:34PM
May-09-23 04:43PM
May-06-23 03:00PM
May-05-23 04:30PM
May-01-23 10:44AM
Apr-14-23 07:08AM
Mar-29-23 05:59PM
04:58PM Loading…
Mar-23-23 09:05AM
Mar-20-23 08:55AM
Mar-12-23 11:44PM
Mar-03-23 10:19AM
Mar-01-23 09:03AM
Feb-28-23 07:08PM
Feb-27-23 04:30PM
Feb-12-23 09:05PM
Feb-06-23 07:38AM
Feb-02-23 12:27PM
Jan-23-23 12:58PM
Jan-13-23 06:54PM
Jan-05-23 01:05AM
Dec-28-22 10:05AM
Dec-16-22 04:04AM
Dec-02-22 12:14AM
Nov-29-22 08:30PM
Nov-24-22 02:26PM
Nov-23-22 10:24AM
Nov-22-22 01:01AM
Nov-16-22 11:04PM
Nov-15-22 04:30PM
Nov-02-22 09:27AM
Oct-31-22 05:45PM
Oct-26-22 01:46PM
Oct-05-22 09:25AM
Sep-29-22 09:02AM
Sep-13-22 12:01PM
Aug-29-22 12:08PM
Aug-26-22 09:03AM
Aug-23-22 04:33PM
Aug-22-22 09:37PM
Aug-11-22 09:53AM
Aug-09-22 04:30PM
Aug-01-22 11:26AM
Jul-26-22 12:49PM
Jul-25-22 12:18PM
Jul-22-22 12:00PM
Jul-18-22 12:18PM
Jul-14-22 10:33AM
Jul-11-22 09:50AM
Jun-29-22 09:06AM
Jun-09-22 10:02AM
Jun-06-22 08:00AM
May-26-22 11:03AM
May-24-22 11:50AM
May-23-22 11:28AM
May-12-22 01:16PM
May-11-22 12:46PM
May-10-22 04:30PM
May-09-22 11:05AM
May-03-22 07:14AM
Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the following segments: Surgical and Vision Care. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner on 1945 and is headquartered in Geneva, Switzerland.